Search frequency for KemOn, known as the first non-clinical CRO company in Korea, has surged recently.


As of 1:31 PM on the 10th, KemOn's stock price is 4,470 KRW, down 4.08% from the previous day, with a trading volume of 14,167,202 shares, which is about 21.73% of the 5-day average trading volume.


On November 4th, KemOn was a market topic with the headline "KemOn weak despite AstraZeneca's vaccine production news for March next year."



※Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automatic article creation algorithm jointly developed by Asia Economy and financial AI specialist Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing